Physician profile
Marc A Lederman
NPI 1538180054
$9,520.67
in general payments reported to CMS, 2019-2025
27 companies · $164 in 2025
The $164 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,639 · 2020: $402 · 2021: $289 · 2022: $889 · 2023: $462 · 2024: $676 · 2025: $164.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,145 · Education: $157.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,144.85 |
| Education | $156.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paragon 28, INC. | $5,000.00 | 2019 | |
| Treace Medical Concepts, INC. | $662.66 | 2022-2024 | |
| Kairos Surgical INC | $580.00 | 2019 | |
| Stryker Corporation | $463.11 | 2019-2024 | Citrefix, Augment Injectable |
| Smith+Nephew, INC. | $317.00 | 2023-2025 | Cannulated Screws, Panta 2, Small Cannulated Screws |
| Integra Lifesciences Corporation | $301.19 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Horizon Therapeutics Plc | $278.65 | 2019-2021 | |
| Davol INC. | $191.04 | 2020 | |
| Osiris Therapeutics INC. | $184.88 | 2019 | |
| Triad Life Sciences INC. | $164.02 | 2022 | |
| Zimmer Biomet Holdings, INC. | $141.82 | 2021-2022 | |
| Zimvie INC. | $136.11 | 2023 | |
| Organogenesis INC. | $134.23 | 2019-2020 | |
| Arthrosurface Incorporated | $127.18 | 2019-2020 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $125.00 | 2019 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $100.00 | 2020 | |
| Bioventus LLC | $98.17 | 2019-2021 | |
| Grt US Holding, INC. | $96.97 | 2021 | |
| Polaris Technology Solutions LLC | $92.30 | 2024 | |
| Kci USA, INC. | $91.15 | 2019 | |
| Medtronic, INC. | $66.53 | 2021-2022 | |
| Next Science LLC | $54.64 | 2022 | |
| Trilliant Surgical LLC. | $35.74 | 2019 | |
| Ossio INC | $27.83 | 2020 | |
| Convatec INC. | $18.57 | 2021 | |
| Hydrofera LLC | $15.95 | 2023 | Hydrofera Blue |
| Merck Sharp & Dohme LLC | $15.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Lederman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.